Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2019 / Cilt: 25 - Sayı: 3

Psoriasis and Pregnancy: Retrospective Evaluation of 47 Pregnancies in a Tertiary Center

Pages
128–132
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: Deterioration of psoriasis in pregnancy was associated with adverse obstetric outcome.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: To evaluate the impact of psoriasis on pregnancy outcomes.
📊
Key Findings & Data:STUDY DESIGN: Data of pregnant women with chronic plaque psoriasis who were followed up at Ha - cet tepe University Hospital between January 1, 2010 and December 31, 2017 were evaluated.
💡
Conclusion & Impact:CONCLUSION: Deterioration of psoriasis in pregnancy was associated with adverse obstetric outcome.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Özet

OBJECTIVE: To evaluate the impact of psoriasis on pregnancy outcomes. STUDY DESIGN: Data of pregnant women with chronic plaque psoriasis who were followed up at Ha - cet tepe University Hospital between January 1, 2010 and December 31, 2017 were evaluated. Pregnant women with singleton pregnancies who had chronic plaque psoriasis were included in the study. Patients were divided into two groups based on the clinical course of psoriasis: group 1 (improvement/disease-stable), and group 2 (deterioration). Median maternal age, gravida, parity, gestational week at birth, birthweight, 5th minute Apgar score together with the rates of cesarean section, neonatal intensive care unit admission and pregnancy complications (spontaneous abortion, preterm delivery, fetal growth restriction and preeclampsia) were compared between the groups. RESULTS: There were 29 (61.7%) patients in group 1 and 18 (38.3%) patients in group 2. Mean values for maternal age, gravida and parity were comparable between the groups (p values were 0.32, 0.09 and 0.17, respectively). Median values for gestational week at birth (39.2 vs 36.1, p=0.002), birthweight (3200 vs 2310, p=0.002) and 5th minute Apgar score (9 vs 7, p<0.001) were statistically significantly lower in group 2. Cesarean section (33.3% vs 71.4%, p=0.02), neonatal intensive care unit admission (11.1% vs 64.3%, p<0.001) and pregnancy complication rates (p=0.003) were statistically significantly higher in group 2. Frequencies of spontaneous abortion, preterm delivery, fetal growth restriction and preeclampsia were 6.9%, 10.3%, 3.4% and 3.4% in group 1, and 22.2%, 27.8%, 16.7% and 16.7% in group 2, respectively. CONCLUSION: Deterioration of psoriasis in pregnancy was associated with adverse obstetric outcome.

🔖

Cite This Article

TANACAN, E., TANAÇAN, A., FADILOĞLU, E., ÜNAL, C., BEKSAÇ, M. S. (2019). Psoriasis and Pregnancy: Retrospective Evaluation of 47 Pregnancies in a Tertiary Center. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 25 - Sayı: 3, 128–132. https://ajindex.com/articles/159630

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Bobotsis R, Gulliver WP, Monaghan K, Lynde C, Fleming P. Psoriasis and adverse pregnancy outcomes: A systematic review of observational studies. Br J Dermatol. 2016;175(3):464-72
  2. Lima XT, Janakiraman V, Hughes MD, Kimball AB. The impact of psoriasis on pregnancy outcomes. J Invest Dermatol. 2012;132(1):85-91
  3. Harden JL, Krueger JG, Bowcock AM. The immunogenetics of psoriasis: a comprehensive review. J Autoimmun. 2015;64:66-73
  4. Krueger J, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis. 2005;64 (suppl 2):ii30-ii6
  5. Huerta C, Rivero E, Rodríguez LAG. Incidence and risk factors for psoriasis in the general population. Arch Dermatol. 2007;143(12):1559-65
  6. Pearce DJ, Morrison AE, Higgins KB, Crane MM, Balkrishnan R, Fleischer AB, Jr., et al. The comorbid state of psoriasis patients in a university dermatology practice. J Dermatolog Treat. 2005;16(5-6):319-23
  7. Brauchli YB, Jick SS, Miret M, Meier CR. Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis. J Invest Dermatol. 2009;129(11):2604-12
  8. Wu JJ, Nguyen TU, Poon KY, Herrinton LJ. The association of psoriasis with autoimmune diseases. J Am Acad Dermatol. 2012;67(5):924-30
  9. Hamilton MP, Ntais D, Griffiths CE, Davies LM; Identification and Management of Psoriasis-Associated ComorbidiTy (IMPACT) Team. Psoriasis treatment and management–a systematic review of full economic evaluations. Br J Dermatol. 2015;172(3):574-83
  10. Murase JE, Chan KK, Garite TJ, Cooper DM, Weinstein GD. Hormonal effect on psoriasis in pregnancy and post partum. Arch Dermatol. 2005;141(5):601-6
  11. Danesh MJ, Murase JE. The new US Food and Drug Administration pregnancy and lactation labeling rules: Their impact on clinical practice. J Am Acad Dermatol. 2015;73(2):310-1
  12. Bernhard JD. Auspitz sign is not sensitive or specific for psoriasis. J Am Acad Dermatol. 1990;22(6 Pt 1):1079-81
  13. Mattei PL, Corey KC, Kimball AB. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies. J Eur Acad Dermatol Venereol. 2014; 28(3): 333-7
  14. Regan L, Rai R. Epidemiology and the medical causes of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14(5):839-54
  15. Sabour S. Prediction of preterm delivery using levels of VEGF and leptin in amniotic fluid from the second trimester: predi